Pharmacological endothelin receptor interaction does not occur in veins from ETB receptor deficient rats

Vascular Pharmacology

Volumn 49, Issue 1, 2008, Pages 6-13

  Thakali, Keshari ^a   Galligan, James J ^a   Fink, Gregory D ^a   Gariepy, Cheryl E ^b   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Aorta; Endothelin receptors; Receptor heterodimerization; Vena cava

Indexed keywords

ATRASENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SARAFOTOXIN;

ANIMAL TISSUE; AORTA; ARTICLE; CAVA VEIN; CELL MEMBRANE; DIMERIZATION; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AORTA, THORACIC; BLOTTING, WESTERN; DATA INTERPRETATION, STATISTICAL; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; VEINS; VENA CAVA, SUPERIOR;

EID: 46749146061     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.03.005     Document Type: Article

References (29)

1. 1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407 (2000) 94-98
2. AbdAlla S., Lother H., el Massiery A., and Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7 (2001) 1003-1009
3. 2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J. Mol. Neurosci. 26 (2005) 185-192
4. Adner M., Uddman E., Cardell L.O., and Edvinsson L. Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture. Cardiovasc. Res. 37 (1998) 254-262
5. Angers S., Salahpour A., Joly E., Hilairet S., Chelsky D., Dennis M., and Bouvier M. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3684-3689
6. Bulenger S., Marullo S., and Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26 (2005) 131-137
7. Claing A., Shbaklo H., Plante M., Bkaily G., and D'Orleans-Juste P. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. Br. J. Pharmacol. 135 (2002) 433-443
8. B receptors expressed in HEK 293 cells. Exp. Biol. Medicine (Maywood) 231 (2006) 746-751
9. Gariepy C.E., Cass D.T., and Yanagisawa M. Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 867-872
10. Gariepy C.E., Williams S.C., Richardson J.A., Hammer R.E., and Yanagisawa M. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. J. Clin. Invest. 102 (1998) 1092-1101
11. Gregan B., Jurgensen J., Papsdorf G., Furkert J., Schaefer M., Beyermann M., Rosenthal W., and Oksche A. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J. Biol. Chem. 279 (2004) 27679-27687
12. Hirata Y., Emori T., Eguchi S., Kanno K., Imai T., Ohta K., and Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J. Clin. Invest. 91 (1993) 1367-1373
13. B receptors differentially modulate afferent and efferent arteriolar responses to endothelin. Br. J. Pharmacol. 146 (2005) 1019-1026
14. Ishikawa K., Ihara M., Noguchi K., Mase T., Mino N., Saeki T., Fukuroda T., Fukami T., Ozaki S., Nagase T., Nishikibe M., and Yano M. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4892-4896
15. Kedzierski R.M., and Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 851-876
16. B receptors in venous and arterial smooth muscle. Eur. J. Pharmacol. 287 (1995) 279-285
17. Maggio R., Novi F., Scarselli M., and Corsini G.U. The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology. FEBS J. 272 (2005) 2939-2946
18. 2-adrenergic receptors within a unique heterodimeric complex. J. Clin. Invest. 116 (2006) 1400-1409
19. B receptors in rat isolated small mesenteric arteries. Br. J. Pharmacol. 120 (1997) 1376-1382
20. Milligan G., and Bouvier M. Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J. 272 (2005) 2914-2925
21. B receptor mRNA in human omental arteries after organ culture: quantification by competitive reverse transcription-polymerase chain reaction. Clin. Exp. Pharmacol. Physiol. 25 (2000) 788-794
22. Perez-Rivera A.A., Fink G.D., and Galligan J.J. Vascular reactivity of mesenteric arteries and veins to endothelin-1 in a murine model of high blood pressure. Vascul. Pharmacol. 43 (2005) 1-10
23. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57 (2005) 289-298
24. Sauvageau S., Thorin E., Caron A., and Dupuis J. Evaluation of endothelin-1-induced pulmonary vasoconstriction following myocardial infarction. Exp. Biol. Medicine (Maywood). 231 (2005) 840-846
25. Thakali K., Fink G.D., and Watts S.W. Arteries and veins desensitize differently to endothelin. J. Cardiovasc. Pharmacol. 43 (2004) 387-393
26. Wallrabe H., and Periasamy A. Imaging protein molecules using FRET and FLIM microscopy. Curr. Opin. Biotechnol. 16 (2005) 19-27
27. Watts S.W., Fink G.D., Northcott C.A., and Galligan J.J. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists. Br. J. Pharmacol. 137 (2002) 69-79
28. Wilson S.J., Dowling J.K., Zhao L., Carnish E., and Smyth E.M. Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 290-296
29. Wu-Wong J.R., Dixon D.B., Chiou W.J., Sorensen B.K., Liu G., Jae H.S., Tasker A., von Geldern T.W., Winn M., and Opgenorth T.J. Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: in vitro studies. Clin. Sci. (Lond) 103 (2002) 107S-111S